Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial
Authors:
- Bulent YilmazBYBulent Yilmaz
- Sefa KelekciSKSefa Kelekci
- Ibrahim Egemen ErtasIEIbrahim Egemen Ertas
- Serkan KahyaogluSKSerkan Kahyaoglu
- Murat OzelMOMurat Ozel
- Necdet SutNSNecdet Sut
- Nuri DanismanNDNuri Danisman
Open Access
- 21 July 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 20 (11) , 3067-3071
Abstract
BACKGROUND: This study was conducted to evaluate the efficacy and side effects of a new regimen of 800 µg misoprostol administered intravaginally every 6 h up to a maximum of three doses in 24 h for second trimester pregnancy termination. METHODS: A total of 66 women seeking termination of second trimester pregnancy (30 fetal structural anomaly, six chromosomal abnormality and 30 fetal death) were randomly assigned to one of two treatment groups: (i) intravaginal misoprostol moistened with 3 ml of 5% acetic acid in group A (n = 33); or (ii) intravaginal misoprostol moistened with 3 ml of saline in group B (n = 33). RESULTS: The overall median (range) induction–abortion interval was 10 h (2–46) [10 h (4–35) in 36 live fetuses and 9 h (2–46) in 30 dead fetuses, P = 0.515]. All of the patients in both groups aborted within 48 h (100% success rate). The median (range) induction–abortion interval revealed a significantly faster delivery time (P < 0.001) in group A [8 h (2–24)] than in group B [14 h (3–46)]. CONCLUSIONS: This new regimen of 800 µg of vaginal misoprostol every 6 h for a maximum of three doses in 24 h was an effective alternative method for second trimester abortion. In addition, misoprostol moistened with acetic acid was significantly more effective than misoprostol moistened with saline.Keywords
This publication has 21 references indexed in Scilit:
- Vaginal misoprostol 800 μg every 12 h for second-trimester abortionContraception, 2004
- Risk Factors for Legal Induced Abortion–Related Mortality in the United StatesObstetrics & Gynecology, 2004
- Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformationAmerican Journal of Obstetrics and Gynecology, 2004
- A randomized trial of saline solution–moistened misoprostol versus dry misoprostol for first-trimester pregnancy failureAmerican Journal of Obstetrics and Gynecology, 2004
- A randomized comparison of two regimens of misoprostol for second-trimester pregnancy terminationAmerican Journal of Obstetrics and Gynecology, 2003
- A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy terminationAmerican Journal of Obstetrics and Gynecology, 2002
- A randomised trial of oral versus vaginal administration of misoprostol for the purpose of mid‐trimester termination of pregnancyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2001
- Misoprostol regimens for termination of second trimester pregnancy.Human Reproduction, 2001
- The effect of vaginal pH on the efficacy of vaginal misoprostol for induction of laborActa Obstetricia et Gynecologica Scandinavica, 2000
- Effect of vaginal misoprostol application for cervical softening in pregnancy interruption before ten weeks of gestationActa Obstetricia et Gynecologica Scandinavica, 1996